Below are 4 news articles from the past week to help guide you in making your decision.

Article 1 of 4
Title: RSV, COVID-19, and Flu Outlook for 2023-2024
Publisher: Johns Hopkins Bloomberg School of Public Health
Posted: 1 day ago
COVID deaths and hospitalizations are at all-time lows.
There's a slight uptick in wastewater surveillance, but no evidence to suggest a significant increase in hospitalizations or deaths.
The flu season was early last year, but not necessarily worse than usual.
A new antibody for RSV has been approved, which may help protect infants against RSV this coming winter.
Experts recommend getting vaccinated against COVID-19, flu, and RSV to prevent hospitalizations and deaths.

Article 2 of 4
Title: Silence from N.B. on COVID-19 fall boosters 'disappointing,' epidemiologist says
Publisher: CBC.ca
Posted: 4 days ago
Key values:
XBB variant is still circulating globally
Booster shots are recommended for people at increased risk of severe disease (e.g. adults 65+, long-term care residents)
Increased protection from boosters can reduce the impact on the healthcare system during the fall and winter respiratory virus season

Article 3 of 4
Title: Top medical experts call for national inquiry into Canada's COVID-19 'failures'
Publisher: CBC News
Posted: 5 days ago
The article discusses Canada's response to the COVID-19 pandemic, highlighting several concerns and criticisms. Some key points include:
1. Multiple large outbreaks: The country experienced numerous deadly outbreaks among essential workers, including hundreds of infections at an Amazon warehouse in Brampton, Ont., and one of the continent's largest outbreaks at an Alberta meat-packing plant.
2. Vaccine hoarding and distribution concerns: While Canada hit high overall vaccination targets, critics argued that shots weren't always reaching the hardest-hit communities. Some provinces developed hot-spot vaccination strategies, but advisory group reports often came out too late.
3. Global vaccine sharing: The federal government was criticized for receiving doses from COVAX while also securing shots through other outside deals. This led to a domestic oversupply of vaccines, with tens of millions facing expiry by the end of 2022.
4. Lack of domestic vaccine manufacturing: Despite having almost 96 million doses administered, Canada had not manufactured any vaccines domestically by the end of 2022, which affected its ability to increase vaccine supply both at home and abroad.
5. Fragmented healthcare system: The article highlights a health-care system that remains fragmented, decentralized, and complex, with different rules in place across provinces and territories.
The BMJ team's analysis suggests that Canada's response to the pandemic was marred by missed opportunities for leadership or coordination, a lack of sharing of data across systems, and a failure to learn from previous crises (such as the SARS outbreak). The authors are concerned that these flaws may be repeated in future public health threats.
Some experts, like Dr. Sharon Straus, are calling for a full federal inquiry into Canada's pandemic response, along with new national standards to reduce the fractured nature of Canadian healthcare and better prepare the country for future pandemics. However, others express skepticism about whether such changes will occur, given Canada's mixed performance during COVID-19.

Article 4 of 4
Title: COVID-19 rapid antigen test kits now available at health unit offices
Publisher: Huntsville Doppler
Posted: 7 days ago
The article mentions a decrease in reported confirmed COVID-19 cases and hospitalizations in Simcoe Muskoka over the past several months. The Community Risk Level has consistently remained at the 'Lower (Caution) level'. This information is relevant for forecasting COVID-19 hospitalizations in Ontario, Canada as it provides context on current trends and risk levels.